RVP RETRACTABLE TECHNOLOGIES INC

NYSE Surgical & Medical Instruments & Apparatus TX CIK: 0000946563
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

Retractable Technologies exhibits severe fundamental deterioration with negative gross margins (-11.7%) indicating core business model dysfunction—the company loses money before operating expenses. Despite 15.8% revenue growth, operating cash flow is negative (-$1.4M) and cash reserves ($2.8M) are insufficient to sustain quarterly burn rates, creating acute runway risk.

Strengths

  • + Revenue growth of 15.8% YoY demonstrates top-line demand
  • + Low leverage (Debt/Equity 0.01x) preserves financial flexibility
  • + Strong liquidity ratios (Current 5.74x, Quick 4.17x) provide short-term cushion

Risks

  • ! Negative gross margin (-11.7%) indicates fundamental pricing or cost structure failure
  • ! Operating cash flow negative at -$1.4M; business is not self-sustaining
  • ! Minimal cash reserves ($2.8M) insufficient relative to quarterly burn rate
  • ! Persistent net losses (-58.9% margin) across all profitability measures
  • ! Cost of goods sold appears to exceed revenue, suggesting product economics are broken

Key Metrics to Watch

Financial Metrics

Revenue
7.2M
Net Income
-4.2M
EPS (Diluted)
$-0.14
Free Cash Flow
-1.4M
Total Assets
137.6M
Cash
2.8M

Profitability Ratios

Gross Margin -11.7%
Operating Margin -85.9%
Net Margin -58.9%
ROE -6.0%
ROA -3.1%
FCF Margin -19.1%

Balance Sheet & Liquidity

Current Ratio
5.74x
Quick Ratio
4.17x
Debt/Equity
0.01x
Debt/Assets
49.1%
Interest Coverage
-184.21x
Long-term Debt
895.6K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-23T09:14:24.222134 | Data as of: 2026-03-31 | Powered by Claude AI